Free Trial
NASDAQ:RCEL

AVITA Medical Q1 2025 Earnings Report

AVITA Medical logo
$9.02 -0.21 (-2.28%)
As of 04:00 PM Eastern

AVITA Medical EPS Results

Actual EPS
N/A
Consensus EPS
-$0.39
Beat/Miss
N/A
One Year Ago EPS
N/A

AVITA Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
$33.15 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

AVITA Medical Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Monday, May 12, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Remove Ads

AVITA Medical Earnings Headlines

AVITA Medical's (RCEL) "Buy" Rating Reiterated at D. Boral Capital
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More AVITA Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AVITA Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AVITA Medical and other key companies, straight to your email.

About AVITA Medical

AVITA Medical (NASDAQ:RCEL), together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

View AVITA Medical Profile

More Earnings Resources from MarketBeat